Boehringer Ingelheim is the exception. It has not announced any major settlements. A drug under the name of Zantac 360, which contains no ranitidine, is still being currently sold.
All trademarks mentioned in this press release are the property of the Sanofi group. 1 Non-IFRS measure. 2 Zantac 360° is included in the scope of the contemplated transaction. 3 Constant exchange ...
A drug under the name of Zantac 360, which does not contain the alleged cancer-causing ingredient ranitidine, is still being sold currently. GSK’s collaboration with Cambridge University comes after ...
How do you explain one Zantac manufacturer kiboshing a favorable trend of defense verdicts and decisions – with a massive $2.2 billion settlement? The answer appears to lie with the whistleblower suit ...
Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.
GSK has also reached an agreement to pay $70 million to resolve the Zantac Qui Tam suit previously filed by Valisure. The arrangement is awaiting final approval from the Department of Justice.
GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.
The Torras Ostand 360° Spin Fusion MagSafe Case is a solid case for the iPhone 16, 16 Pro, and 16 Pro Max with a unique twist. The metal ring on the back serves as a magnet to align the case ...
Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing ...
Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Unfortunately, there aren't many details available in the FCC listing. The filing only went ...